BioAdvance
BioAdvance is a venture capital firm based in Philadelphia, United States, focused on Pre-Seed to Series B startups in Healthcare & Biotech, Biotech & Pharma, and MedTech & Medical Devices. This profile covers its focus and how founders can get in front of it in 2026.
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
- Investment focus
- Healthcare & BiotechBiotech & PharmaMedTech & Medical DevicesDigital Health & HealthTechArtificial Intelligence
- Investment stages
- Pre-SeedSeedSeries ASeries B
- Location
- Philadelphia, United States
- Founded
- 2003
- Team size
- 1-10
- Portfolio companies
- 69+
About BioAdvance
BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its new $50 million Greenhouse Fund. They invest in therapeutics, devices, diagnostics and platform technologies focused on human health.
Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date they have committed more than $40 million to more than 50 seed-stage companies and 17 pre-seed companies. Their portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies.
Source: the organization's public company profile.
How to pitch BioAdvance
The founders who hear back from BioAdvance lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with BioAdvance
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "BioAdvance." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/bioadvance
Frequently Asked Questions
What does BioAdvance invest in?
BioAdvance focuses on Healthcare & Biotech, Biotech & Pharma, MedTech & Medical Devices, and Digital Health & HealthTech. Match your sector and stage before reaching out, then find similar active investors on Round Funded.
What stage does BioAdvance invest at?
BioAdvance focuses on Pre-Seed to Series B rounds. Lead with traction that fits the stage when you reach out.
Is BioAdvance actively investing?
Yes. Round Funded's research found that BioAdvance has made a new investment or run a new cohort since 2024. Reach out with a personalized pitch that fits its stage and focus, then track who opens it.
Where is BioAdvance based?
BioAdvance is based in Philadelphia, United States. You can reach out from anywhere with a pitch that matches its focus.
How do I contact BioAdvance?
Unlock a verified email for BioAdvance and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.